IL-4 Diminishes Perforin-Mediated and Increases Fas
C ytokines are key modulators in the development of CTL. IL-2, IFN-␥, IL-6, IL-7, IL-12, and IL-15 have been shown to be important for the proliferation of Ag-activated CTL (1-4), whereas IL-4 has been shown to down-regulate CTL activity. Recent studies using IL-4-secreting recombinant vaccinia virus, IL-4 knockout mice, IL-4 overexpressing mice, or immune-complexed IL-4 have indicated that IL-4 diminishes CTL activity in vivo (5) (6) (7) (8) (9) ). Yet the mechanism by which IL-4 diminishes CTL activity remains unknown.
CTL are able to lyse target cells by two mechanistically distinct but functionally similar mechanisms (10 -14) : a Ca 2ϩ -dependent perforin/granzyme mechanism and a Ca 2ϩ -independent Fas (CD95)/Fas ligand (L, 3 CD95L) mechanism. Perforin/granzyme killing requires the presence of Ca 2ϩ for polymerization of the "pore-forming" protein perforin (13, 14) . Once perforin polymerizes, it acts as a conduit for serine esterases such as granzymes to aid in lysis of the target cell. CTL that kill target cells by the perforin method are Ag specific, and therefore only recognize target cells displaying specific Ag bound to MHC class I. Alternatively, the Fas/FasL pathway is Ca 2ϩ independent; lysis of the target cell only requires the presence of Fas Ag on the target cell surface (15, 16) . Thus, the Fas/FasL pathway of killing is not Ag specific or MHC restricted (17, 18) ; therefore, Fas-expressing cells may be lysed regardless of infection. In addition, target cell lysis by preformed perforin and granzymes is faster (half-life of 7-10 min (19, 20) ) than Fas/FasL killing, which triggers a series of apoptotic signals over a period of several hours before DNA fragmentation occurs (21) . Although both mechanisms of CTL-mediated target cell lysis are clearly documented, the function and differential regulation of these to pathways is not well defined. The perforin/granzyme exocytosis pathway is considered to be important in elimination of virus-infected and tumorigenic cells (22) (23) (24) , whereas the Fas/FasL mechanism of killing is thought to play an important role in eliminating autoreactive T cells (25) (26) (27) , even though perforin has been shown to be involved in down-regulating T cell response during chronic lymphocytic choriomeningitis virus infection (28) . Thus, CTL have evolved two key mechanisms for target cell killing; how and why one pathway is activated over the other remains to be elucidated.
Respiratory syncytial virus (RSV) is a ubiquitous human pathogen that can cause severe illness and even death in infants and young children. Studies in humans and animal models of RSV infection have suggested IL-4 as a participant in severe RSV disease (6, 29 -31) . We have demonstrated that IL-4-overexpressing mice infected with RSV experience a diminished CTL response and severe RSV illness marked by increased lung immunopathology as compared with wild-type controls (6). BALB/c (H-2 d ) mice infected with RSV recognize the viral matrix protein M2 as a major target Ag for induction of CD8 ϩ CTL (32) . Using recombinant vaccinia viruses (rVV) expressing RSV Ag M2 (vvM2) or coexpressing M2 and IL-4 (vvM2/IL-4), we showed that IL-4 expressed locally, at the time of Ag presentation, impaired Ag-specific CTL function in vivo (5) . In this study, we show that effectors from vvM2/IL-4-infected mice express an increased level of FasL on CD4 ϩ and CD8 ϩ T cells as compared with vvM2-infected mice. In addition, vvM2/IL-4-infected mice lyse L1210Fas ϩ target cells treated with EGTA/Mg 2ϩ with 10-fold greater magnitude as compared with vvM2-infected mice. These data demonstrate that IL-4 induces an increase in Ca 2ϩ -independent FasL-mediated target cell killing while diminishing Ca 2ϩ -dependent perforin-mediated killing.
Materials and Methods

Mice
Eight-to 10-wk pathogen-free BALB/c mice, purchased from Harlan Laboratories (Indianapolis, IN), were housed and cared for in accordance with the Guide for the Care and Use of Laboratory Animals as described previously (33) . Mice were injected in the tail vein with 5 ϫ 10 6 PFU of rVV and sacrificed at the indicated times after infection. Viruses rVV (WR strain) containing the RSV M2 protein (vvM2) was a gift from Dr. Peter L. Collins (NIH). rVV containing ␤-galactosidase was a gift from Dr. Bernard Moss (NIH). The plasmid encoding IL-4 was provided by Ian A. Ramshaw (Australia National University, Canberra, Australia). Construction of recombinant virus has been described in detail elsewhere (5, 35, 36) . Briefly, the vvM2/IL-4-coexpressing vector was constructed by the insertion of a chimeric promoter-cytokine fragment into the HindIII-F region of the vvM2. The selection, plaque purification, and concentration of recombinant viruses were performed as described elsewhere (37) . IL-4 secretion by rVV was detected by ELISA on infected cell culture supernatant using commercial kits purchased from Endogen (Cambridge, MA). 
Cell lines
P815 (H-2 d ),
Synthetic peptides
Cytotoxic T cell assays
Mice infected i.v. with 5 ϫ 10 6 PFU of rVV were sacrificed at the indicated times after infection. Spleens cells were treated with sterile water for 15 s, and the remaining cells were washed twice, counted, and then resuspended in RPMI 1640 containing 10% FBS. An aliquot was set aside for FACS staining. Target cells were incubated with 100 ml of peptide (0.1 mg/ml) and 51 Cr (100 mCi/10 7 cells) for 60 min at 37°C, washed three times in 10% EMEM, and distributed in V-bottom 96-well plates (Costar, Cambridge, MA) at 2 ϫ 10 4 cell/100 l/well. A total of 5 g/ml purified anti-FasL Ab (clone MFL3) or isotype control IgG (clone A19-3; PharMingen, San Diego, CA) was added to appropriate cells and incubated at room temperature for 15 min before distribution. Use of Fas.IgG (10 g/ ml) fusion protein blocked killing as well as anti-FasL (data not shown). Splenic effector cells were added at a ratio of 100:1 (E:T) and serially diluted down to 3:1 in triplicate. Only data for E:T ratios of 100:1 are shown. A total of 4 mM/3 mM, respectively, EGTA/Mg 2ϩ or PBS was added to appropriate wells, and the plate was centrifuged at 150 ϫ g for 30 s before incubation at 37°C for 4 h for L1210Fas Ϫ targets and 8 h for L1210Fas ϩ targets. The cells were pelleted and 50 ml of the supernatant was counted in a 96-well TopCount NXT gamma counter (Packard, Meriden, CT). Spontaneous and total release were measured by treating the targets cells with 10% RPMI 1640 or with 5% Triton X-100 detergent, respectively. Specific release of 51 Cr from target cells is defined as 100 ϫ [sample cpm (cpm) Ϫ background cpm]/[total cpm Ϫ background cpm].
Surface staining and flow cytometry
A total of 2 ϫ 10 6 spleen cells was washed once in staining buffer (PBS/ 0.1%sodium azide/2%FCS) and surfaced stained with Cy-Chrome-conjugated monoclonal rat anti-mouse CD8␣ (clone 53-6.7) Ab, FITC-conjugated monoclonal rat anti-mouse CD4 (clone GK1.5), and PE-conjugated monoclonal hamster anti-mouse FasL (clone MFL3), or PE-CD44 (clone IM7), PE-LFA-1 ␣-chain (clone 2D7), and PE-L-selectin (clone MEL-14; PharMingen). Cells were washed twice in staining buffer and three-color analysis was performed on a FACSCaliber (Becton Dickinson, San Jose, CA) argon-ion laser at 15 mW and 488 nm. Forty thousand events were collected at an average of 1000 events/s. Data were analyzed using CellQuest version 3.1 (Becton Dickinson).
Apoptosis assays and enumeration of M2-specific CD8
ϩ T cells
For enumeration of RSV M2-specific CD8 ϩ T cells using H-2K d tetramers, 1 ϫ 10 6 cells were stained with PE-labeled influenza NP or RSV M2 tetramers, a gift from Dr. John Altman (Emory University, Atlanta, GA), and allophycocyanin (APC)-conjugated rat anti-mouse CD8␣ (clone 53-6.7; PharMingen), FITC-annexin V (R&D Systems, Minneapolis, MN), and vital dye 7-amino-actinomycin D (7-AAD; PharMingen). Another experiment was performed using FITC-CD4, Cy-Chrome-CD8, and PE tetramer and showed that only CD8 ϩ cells bound the tetramer (data not shown). vvIL-4-and vvLac-infected mice were used as a control for M2-specific tetramer staining (data not shown). For apoptosis assays, 1 ϫ 10 6 spleen cells were stained with PE-labeled RSV M2 or influenza NP-specific MHC class I tetramers and allophycocyanin-CD8 for 30 min at 4 o C. Cells were washed twice with PBS and stained with FITC-annexin V according to the manufacturer's instructions (R&D Systems). Vital dye 7-AAD was used to distinguish dead cells from apoptotic cells. Four-color flow cytometric analysis was performed using a FACSCaliber (Becton Dickinson) argon-ion laser at 15 mW and 488 nm and red diode laser ϳ635 nm. One hundred thousand events were collected and data were analyzed using CellQuest version 3.1 (Becton Dickinson).
Statistics
Statistical analysis was done using Corel QuattroPro version 6.0 for Windows. Two-tailed Student's t test was used for comparison of means, and values of p Ͻ 0.05 were considered to be statistically significant.
Results
IL-4 up-regulates FasL expression on CD4
ϩ and CD8 ϩ T cells
Activation of naive T cell precursors is an early event in CTL development. Changes in surface expression of adhesion molecules such as LFA-1 and L-selectin is one consequence of T cell activation (39 -41) . Based on previous observations showing that IL-4 diminishes CTL activity, the hypothesis that IL-4 may interfere with T cell activation was tested. Activation markers CD44 high , L-selectin low , and LFA-1 high were assessed using a multiparameter flow cytometric analysis. These CD8 ϩ T cell activation markers from splenocytes of vvM2-or vvM2/IL-4-infected mice were similar on all days tested after infection (Fig. 1A) and also similar on CD4 ϩ T cells between groups (data not shown). Interestingly, analysis of FasL expression showed that vvM2/IL-4-infected mice had Ͼ9-fold increase of surface FasL on CD8 ϩ (6-fold on CD4 ϩ ) cells on day 4, and a 4-fold increase on CD8 ϩ cells 6 days after infection compared with vvM2-infected mice (Fig. 1B) .
To further establish that secreted IL-4 induced the observed increase in FasL expression, anti-IL-4 was administered i.p. for 5 days starting on day Ϫ2 and ending day ϩ2. On day 4 after infection, anti-IL-4 treatment completely blocked the IL-4-induced increase in FasL expression on T cells, whereas isotype control Ab had no effect (Fig. 2) .
IL-4 primed effectors lyse target cells by two distinct pathways
Initial studies utilizing Fas-deficient target cells demonstrated that IL-4 diminished Ag-specific CTL activity in vivo (5-9). Since these target cells express very little Fas protein, it can be reasoned that Ag-specific CTL killing was predominantly perforin mediated.
To address the possibility that IL-4-primed effectors could lyse Fas ϩ target cells by way of FasL, we used L1210Fas ϩ and L1210Fas Ϫ target cells. IL-4 diminished Ag-specific CTL lysis of M2-sensitized L1210Fas Ϫ targets (Fig. 3A) . These data are consistent with previous findings using conventional P815 target cells that express low levels of Fas (5, 7). Strikingly, when Fas was overexpressed on the surface of target cells, cytotoxicity in the vvM2/IL-4 group increased to levels similar to those of mice infected with vvM2 (Fig. 3B) . Since Fas/FasL-mediated target cell lysis is slower than perforin-mediated killing, L1210Fas ϩ target cells were incubated with effectors for 8 h rather than the standard 4-h incubation. To further control for time effects on perforinmediated lysis, CTL effectors were also incubated with L1210Fas 
IL-4-primed effectors lyse target cells predominantly by way of Fas/FasL
To further distinguish perforin-mediated (Ca 2ϩ dependent) from FasL-mediated (Ca 2ϩ independent) target cell killing, we used M2 peptide-sensitized L1210Fas ϩ as target cells. EGTA/Mg 2 ϩ was added to effector and target cells to differentiate perforin and FasL pathways. Perforin-dependent killing is defined here as the total percent lysis minus percent lysis in the presence of EGTA/Mg 2ϩ . Whereas FasL-mediated killing is represented as the percent lysis in the presence of EGTA/Mg 2ϩ . As shown in Fig. 4 , comparison of perforin-(hatched bars) vs FasL-mediated lysis (dotted bars) reveal that FasL-mediated killing is slightly higher in vvM2-infected mice compared with perforin-mediated killing. In sharp contrast, in vvM2/IL-4-infected mice, FasL-mediated killing is 10-fold higher than perforin-mediated killing ( p Ͻ 0.001). This demonstrates that the dominant lytic pathway in vvM2/IL-4-infected mice is Ca 2ϩ independent. Furthermore, comparison of perforinmediated lysis between the two groups further supports the observation that IL-4 diminishes perforin-mediated lysis by effector 
FIGURE 3. Percent specific lysis of M2-sensitized L1210Fas
Ϫ and L1210Fas ϩ target cells. Mice were sacrificed on days 4 and 6 after infection and spleen cells were analyzed for cytolytic activity in a direct 51 Cr release assay. Effectors were incubated with L1210Fas
Ϫ
target cells for 4 h (A), L1210Fas ϩ target cells for 8 h (B), or L1210Fas
Ϫ target cells for 8 h (C). There were significant differences (p Ͻ 0.05) comparing effectors from vvM2-and vvM2/IL-4-infected groups using L1210Fas targets with a 4-h incubation at days 4 and 6 (A) and with an 8-h incubation at day 4 (C). All values are for an E:T ratio of 100:1. Data are representative of three independent experiments; uninfected (n ϭ 1) and rVV infected (n ϭ 4). Fig. 3) . Similarly, target cell killing by the vvM2/IL-4 group shows that L1210Fas ϩ cells were lysed with 2.7-and 2.4-fold greater magnitude than L1210Fas Ϫ target cells on days 4 and 6, respectively; 50.8% (L1210Fas ϩ ) compared with 18.9% (L1210Fas Ϫ ) on day 4 and 46.6% (L1210Fas ϩ ) compared with 19.5% (L1210Fas Ϫ ) on day 6 (Fig. 3, A and B) (E:T, 100:1). Thus, using two independent methods, Fas-negative and Fas-positive target cells and EGTA/Mg 2ϩ , we conclude that IL-4 diminishes perforin-mediated cytotoxicity with a concomitant increase in FasL-mediated cytotoxicity.
CTL (compare with
Fas/FasL-mediated killing is nonspecific and blocked by anti-FasL
To further define whether vvM2/IL-4-infected cells kill by way of the Fas/FasL pathway, nonspecific influenza peptide-sensitized L1210Fas ϩ target cells were used. In vivo, perforin-mediated CTL target cell killing is highly regulated, involving specific Ag-MHC interactions with an infected target cell. However, FasL-mediated target cell killing is nonspecific; any cell that bears Fas in the vicinity of a T cell, regardless of virus infection, may be lysed (42) . Thus, lysis of target cells by vvM2/IL-4-primed effectors should be similar whether target cells are sensitized with specific peptide (RSV M2) or nonspecific peptide (influenza NP). We found that specific lysis of M2 peptide-labeled target cells by splenocytes from vvM2-infected mice was 47% compared with 10% when target cells were sensitized with influenza peptide. In contrast, using splenocytes from vvM2/IL-4-infected mice, specific lysis of RSV M2 peptide-labeled target cells was 51% and 33% for influenza NP-labeled target cells, respectively (Fig. 5A) . Anti-FasL Ab reduced specific lysis of RSV M2-labeled target cells by only 20% using effectors from the vvM2-infected mice, but by more than 40% using effectors from vvM2/IL-4-infected mice (data not shown). As expected, anti-FasL reduced specific lysis of influenza NP-labeled target cells by Ͼ60% (Fig. 5B) . These data suggest that the dominant pathway of killing for effectors from vvM2-infected mice is Ag specific and perforin mediated, whereas the mechanism of CTL-mediated lysis for effectors from mice infected with vvM2/ IL-4 is shifted more toward the Fas/FasL pathway.
Characterization of M2-specific CD8
Previously we showed that IL-4 reduced the frequency of IFN-␥ producing M2-specific CD8 ϩ T cells, suggesting that IL-4 either diminished the clonal burst size or increased the clearance of M2-specific CD8 ϩ T cells (5) . Alternatively, the effect of IL-4 could be only at the level of T cell function, and not T cell number. To address these possibilities directly, PE-labeled M2-specific H-2K d tetramer was used to enumerate the frequency of M2-specific CD8 ϩ T cells by flow cytometry. An influenza NP peptide bound to the H-2K d tetramer was used as a negative control. We found that both groups of mice had similar percentages of M2-specific CD8 ϩ T cells on day 4 after infection, 3.04% Ϯ 0.2 average for vvM2 and 3.25% Ϯ 0.6 average for vvM2/IL-4 (Fig. 6) . In uninfected mice stained with RSV M2 tetramer and vvM2-infected mice stained with control influenza NP tetramer, the frequency of staining was Ͻ0.4% (Fig. 6 ). This suggests that although IL-4 may functionally impair CTL, it does not decrease the number of Agspecific CTL and supports the hypothesis that clonal burst size is not diminished.
Based on observations that suggest FasL may be involved in T cell homeostasis, we then asked whether FasL-expressing CD8 ϩ T cells may be killing other CD8 ϩ T cells. To address this possibility, RSV M2 tetramer-positive and -negative populations were analyzed for apoptosis using four-color flow cytometry. The analysis was gated on CD8 ϩ cells, then either M2-negative (CD8 ϩ :RSV M2 Ϫ ) or M2-positive (CD8 ϩ :RSV M2 ϩ ) populations. Cells were then evaluated for FITC-annexin V and vital dye 7-AAD labeling. Annexin V/7-AAD double-positive populations represent dead cells and annexin V single-positive cells represent apoptotic cells. As show in Fig. 7A , the percentages of apoptotic M2 tetramernegative population is similar in both groups of mice, 47% Ϯ 0.5 average for vvM2, and 49% Ϯ 3.6 average for vvM2/IL-4. We observed greater apoptosis of M2 tetramer-positive cells compared with M2 tetramer-negative CD8 ϩ cells, but there was no difference ). On day 6, FasL-mediated lysis was greater in vvM2/IL-4-infected mice; however, this was statistically insignificant (data not shown). Lysis by effectors from uninfected mice averaged Ͻ5.0% (data not shown). All values are for E:T ratios of 100:1. Data are representative of three independent experiments (n ϭ 5). in apoptotic rates between the two groups of mice, 93% Ϯ 1.5 and 88.6% Ϯ 3.8, for vvM2 and vvM2/IL-4, respectively (Fig. 7B) . Uninfected mice had a small percentage of apoptotic cells (9.1%) and dead cells (2.0%) (Fig. 7A ) . Notably, we found that the number of dead (7-AAD and annexin V double-positive) CD8 ϩ T cells in the vvM2/IL-4-infected mice was 2-fold greater (14% Ϯ 2.2) as compared with vvM2-infected mice (7% Ϯ 0.8) (Fig. 7B) , suggesting that bystander CD8 ϩ T cells killing may be increased in the vvM2/IL-4 group, but there was no evidence for increased lysis of M2 tetramer-positive cells in the vvM2/IL-4 group. These data support the hypothesis that IL-4 is affecting the function of CD8 ϩ T cell effectors and not their number.
Discussion
Cytokines can profoundly influence T cell development in vitro and in vivo. IL-4 has been shown to attenuate virus-specific CTL effector function in vivo. To define the mechanism of IL-4 influence on CTL development, rVV expressing a viral CTL epitope alone or coexpressed with IL-4 were used.
A requisite step in CTL development is activation of naive circulating T cells that subsequently display typical surface activation markers (39 -41) . Analysis of activation markers shows that in the presence or absence of IL-4, both groups of mice have similar levels of CD44 high , LFA-1 high , and L-selectin low surface expression on T cells. Thus, we conclude that IL-4 diminution of CTL activity is not by way of impaired T cell activation. Interestingly, we found that IL-4 up-regulates FasL expression on T cells and that the levels of FasL expression correlate with the magnitude of FasL-mediated killing. To distinguish perforin-mediated from FasL-mediated killing, EGTA/Mg 2ϩ was added to effector and target cells. The presence of IL-4 during priming of effector CTL results in greater FasL-mediated killing and less perforin-mediated killing. In the absence of IL-4, effectors develop strong perforinmediated lytic activity, with a minor contribution from FasL-mediated killing (Fig. 3 ). These data demonstrate that IL-4 induces expression of FasL on the surface of T cells, resulting in an altered balance of perforin-and Fas/FasL-mediated cytolysis.
The precise role of the Fas/FasL mechanism of killing in vivo is controversial. However, the prevailing thought is that the primary function of FasL-mediated killing is to eliminate autoreactive T cells and downsize immune response after infection (25) (26) (27) 43) . The importance of Fas/FasL in T cells homeostasis and regulation of autoreactive T cells has been illustrated in mice genetically deficient in Fas (lpr) or FasL(gld) (44 -46) . Thus, the Fas/FasL pathway of killing is essential for immune regulation. In vitro, CD4 ϩ T cells have been shown to eliminate CD8 ϩ T cells by Fas/FasL-mediated apoptosis (47) . However, downsizing of the immune response by way of Fas/FasL may not be beneficial since effectors necessary for disease resolution may be eliminated too early. Precedence for early regulation of Ag-specific CTL during a virus infection comes from studies in SIV-infected rhesus macaques. Gag peptide-specific tetramers were used to enumerate and phenotype peptide-specific CTL in vivo and showed that clonal elimination of effector CTL response can occur before peak CTL response develops (48) , although no role of Fas/FasL was postulated. In our previous studies, we found that IL-4 can decrease the frequency of IFN-␥-producing, M2-specific CD8
ϩ CTL on day 6 after infection, suggesting that frequencies of M2-specific CTL may also be attenuated (5) . In this study, coexpression of IL-4 did not diminish M2-specific CTL frequency measured directly by M2 FIGURE 6. Enumeration of RSV M2-specific CD8 ϩ T cells using MHC class I tetramers. A total of 1 ϫ 10 6 cells was stained with PElabeled influenza NP or RSV M2 tetramers and APC-labeled-CD8, and 100,000 events were collected for flow cytometric analysis. A, Uninfected ϩ RSV M2 tetramer. B, vvM2-infected ϩ influenza NP tetramer. C, vvM2-infected ϩ RSV M2 tetramer. D, vvM2/IL-4-infected ϩ RSV M2 tetramer. Separate experiments were performed using FITC-CD4, Cy-Chrome-CD8, and PE-tetramer and showed that only CD8 ϩ cells were tetramer double positive (data not shown). Data are representative of two independent experiments (n ϭ 4 and 5). peptide-H2K d tetramer binding. These data suggest that the number of M2-specific CD8 ϩ CTL is not affected by IL-4, even though it is clear that IL-4 has altered M2-specific CTL function.
Although the primary role of Fas/FasL-mediated killing is thought to be maintenance of amplified T cells, its potential role in lysis of virus-infected cells has also been reported (49 -51) . The observation that RSV infection can increase Fas expression on epithelial cells (52) further supports the potential role for Fas/FasL interaction mediating viral clearance. Although Fas/FasL may participate in the clearance of virus-infected cells, the cost of immunopathology may be higher due to increased potential for bystander lysis. In RSV infection and other animal models of infectious diseases, aberrantly high levels of IL-4 have been shown to be associated with enhanced disease (6, (53) (54) (55) (56) . Previously, we have shown systemic production of IL-4, using IL-4-overexpressing mice (IL-4OE), results in severe immunopathology along with an attenuation of RSV-specific CTL activity as compared with wild-type controls (6) and continued these studies to show that local expression of IL-4, during the time of Ag presentation, diminishes primary RSV-specific CTL activity in vivo (5) . Thus, in animal models of RSV disease, IL-4 has been directly associated with an increase in disease severity and diminished CTL activity. How IL-4 negatively effects the cytolytic activity in response to RSV infection or other infectious diseases is unknown. We conclude that previous observations showing that IL-4 decreased Agspecific CTL activity may have been due to the diminished Fas expression on target cells and not necessarily diminished total cytotoxic capacity of CTL. In vivo, FasL may be functioning to downsize the immune response, but in the setting of higher IL-4 production, FasL expression is increased on CD8 ϩ T cells, and may result in increased bystander lysis to enhance immunopathology and disease severity. Defining the precise role of IL-4-induced FasL-mediated killing is important for our basic understanding of the host immune response to viral infection and for developing effective immunomodulatory approaches for vaccines and therapy.
